Inter-Platform comparability of microarrays in acute lymphoblastic leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and has been the poster-child for improved therapeutics in cancer, with life time disease-free survival (LTDFS) rates improving from <10% in 1970 to >80% today. There are numerous known genetic prognostic va...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Stephanie A, Brown, Kevin M, Henry, Michael M, Mintz, Michelle, Catchpoole, Daniel, LaFleur, Bonnie, Stephan, Dietrich A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522810/
https://www.ncbi.nlm.nih.gov/pubmed/15387886
http://dx.doi.org/10.1186/1471-2164-5-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522810/
https://www.ncbi.nlm.nih.gov/pubmed/15387886
http://dx.doi.org/10.1186/1471-2164-5-71

Ejemplares similares